0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Therapy CDMO Market Research Report 2025
Published Date: 2025-12-26
|
Report Code: QYRE-Auto-35T14289
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Therapy CDMO Market Research Report 2023
BUY CHAPTERS

Global Cell Therapy CDMO Market Research Report 2025

Code: QYRE-Auto-35T14289
Report
2025-12-26
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Therapy CDMO Market Size

The global market for Cell Therapy CDMO was valued at US$ 2150 million in the year 2024 and is projected to reach a revised size of US$ 3694 million by 2031, growing at a CAGR of 8.1% during the forecast period.

Cell Therapy CDMO Market

Cell Therapy CDMO Market

Cell Therapy CDMO is an outsourcing model that provides customized R&D and manufacturing services for cell therapy products, covering the entire process from early-stage process development to commercial production. Its services include cell collection, isolation, amplification, genetic engineering, quality testing, and GMP-compliant aseptic manufacturing and stability studies. Through specialized technology platforms and standardized production systems, Cell Therapy CDMO helps pharmaceutical companies and research institutions address the core challenges of scaling, consistency, and regulatory compliance for live cell products, significantly accelerating the translation process from laboratory to clinical applications and reducing R&D risks and costs.
The cost structure of a Cell Therapy CDMO primarily includes investment in highly skilled R&D personnel, highly customized and expensive GMP production equipment and disposable consumables, as well as extremely stringent quality control and third-party testing fees. Its gross profit margin typically ranges from 35% to 55%, with the core drivers being the specialization and uniqueness of its technology platform, the efficiency of its production processes, and capacity utilization. Personalized therapies face cost pressures due to scale limitations and supply chain complexity, while generic therapies, if mass production and process standardization can be achieved, are more likely to achieve higher profitability.
The global development of cell therapy CDMO presents a pattern of "three-pronged leadership and regional deepening." North America, as the absolute center of technology and market, boasts the most mature biotechnology ecosystem, leading CDMO companies, and an active capital market, dominating industry standards and innovation directions. Europe, with its strong research foundation and rigorous regulatory system, possesses formidable strength in advanced therapies, particularly excelling in academic translation and specialized technology platforms. The Asia-Pacific region is the core engine of global growth. Driven by strong policies, continuous capital investment, and huge clinical demand, China is rapidly upgrading from capacity absorption to technological innovation, while South Korea and Japan are also accelerating their expansion. Currently, supply chain resilience, regulatory differences, and the need for close clinical application are prompting global capacity layout to become more regionalized and decentralized, forming a multi-center collaborative network.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CDMO.
The Cell Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, by Commercial Stage and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Therapy CDMO Market Report

Report Metric Details
Report Name Cell Therapy CDMO Market
Accounted market size in year US$ 2150 million
Forecasted market size in 2031 US$ 3694 million
CAGR 8.1%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Autologous Cell Therapy CDMO
  • Allogeneic Cell Therapy CDMO
  • Viral Vector and Gene Editing CDMO
Segment by Commercial Stage
  • Early-stage R&D CDMO
  • Clinical Stage CDMO
  • Commercial Production CDMO
Segment by Production Mode
  • Centralized Factory Model
  • Distributed Regional Production Model
Segment by Application
  • Commercial
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Lonza, Charles River, FUJIFILM Diosynth Biotechnologies, Exothera, Pharmaron, OBiO, AGC Biologics, Cytiva, ThermoGenesis, eXmoor Pharma, Advanced Therapies, Catalent Biologics, Patheon Pharma Services, Sartorius, Genezen, The Discovery Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Commercial Stage etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Therapy CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell Therapy CDMO Market growing?

Ans: The Cell Therapy CDMO Market witnessing a CAGR of 8.1% during the forecast period 2026-2031.

What is the Cell Therapy CDMO Market size in 2031?

Ans: The Cell Therapy CDMO Market size in 2031 will be US$ 3694 million.

Who are the main players in the Cell Therapy CDMO Market report?

Ans: The main players in the Cell Therapy CDMO Market are Catalent, Lonza, Charles River, FUJIFILM Diosynth Biotechnologies, Exothera, Pharmaron, OBiO, AGC Biologics, Cytiva, ThermoGenesis, eXmoor Pharma, Advanced Therapies, Catalent Biologics, Patheon Pharma Services, Sartorius, Genezen, The Discovery Labs

What are the Application segmentation covered in the Cell Therapy CDMO Market report?

Ans: The Applications covered in the Cell Therapy CDMO Market report are Commercial, Academic Research, Others

What are the Type segmentation covered in the Cell Therapy CDMO Market report?

Ans: The Types covered in the Cell Therapy CDMO Market report are Autologous Cell Therapy CDMO, Allogeneic Cell Therapy CDMO, Viral Vector and Gene Editing CDMO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous Cell Therapy CDMO
1.2.3 Allogeneic Cell Therapy CDMO
1.2.4 Viral Vector and Gene Editing CDMO
1.3 Market by Commercial Stage
1.3.1 Global Cell Therapy CDMO Market Size Growth Rate by Commercial Stage: 2020 VS 2024 VS 2031
1.3.2 Early-stage R&D CDMO
1.3.3 Clinical Stage CDMO
1.3.4 Commercial Production CDMO
1.4 Market by Production Mode
1.4.1 Global Cell Therapy CDMO Market Size Growth Rate by Production Mode: 2020 VS 2024 VS 2031
1.4.2 Centralized Factory Model
1.4.3 Distributed Regional Production Model
1.5 Market by Application
1.5.1 Global Cell Therapy CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Commercial
1.5.3 Academic Research
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy CDMO Market Perspective (2020-2031)
2.2 Global Cell Therapy CDMO Growth Trends by Region
2.2.1 Global Cell Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Therapy CDMO Historic Market Size by Region (2020-2025)
2.2.3 Cell Therapy CDMO Forecasted Market Size by Region (2026-2031)
2.3 Cell Therapy CDMO Market Dynamics
2.3.1 Cell Therapy CDMO Industry Trends
2.3.2 Cell Therapy CDMO Market Drivers
2.3.3 Cell Therapy CDMO Market Challenges
2.3.4 Cell Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy CDMO Players by Revenue
3.1.1 Global Top Cell Therapy CDMO Players by Revenue (2020-2025)
3.1.2 Global Cell Therapy CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Cell Therapy CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Therapy CDMO Revenue
3.4 Global Cell Therapy CDMO Market Concentration Ratio
3.4.1 Global Cell Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CDMO Revenue in 2024
3.5 Global Key Players of Cell Therapy CDMO Head office and Area Served
3.6 Global Key Players of Cell Therapy CDMO, Product and Application
3.7 Global Key Players of Cell Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy CDMO Breakdown Data by Type
4.1 Global Cell Therapy CDMO Historic Market Size by Type (2020-2025)
4.2 Global Cell Therapy CDMO Forecasted Market Size by Type (2026-2031)
5 Cell Therapy CDMO Breakdown Data by Application
5.1 Global Cell Therapy CDMO Historic Market Size by Application (2020-2025)
5.2 Global Cell Therapy CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Therapy CDMO Market Size (2020-2031)
6.2 North America Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Therapy CDMO Market Size by Country (2020-2025)
6.4 North America Cell Therapy CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy CDMO Market Size (2020-2031)
7.2 Europe Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Therapy CDMO Market Size by Country (2020-2025)
7.4 Europe Cell Therapy CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy CDMO Market Size (2020-2031)
8.2 Asia-Pacific Cell Therapy CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Therapy CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Therapy CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Therapy CDMO Market Size (2020-2031)
9.2 Latin America Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Therapy CDMO Market Size by Country (2020-2025)
9.4 Latin America Cell Therapy CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy CDMO Market Size (2020-2031)
10.2 Middle East & Africa Cell Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Therapy CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Therapy CDMO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Cell Therapy CDMO Introduction
11.1.4 Catalent Revenue in Cell Therapy CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Cell Therapy CDMO Introduction
11.2.4 Lonza Revenue in Cell Therapy CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Cell Therapy CDMO Introduction
11.3.4 Charles River Revenue in Cell Therapy CDMO Business (2020-2025)
11.3.5 Charles River Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CDMO Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Exothera
11.5.1 Exothera Company Details
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CDMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CDMO Business (2020-2025)
11.5.5 Exothera Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Details
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Cell Therapy CDMO Introduction
11.6.4 Pharmaron Revenue in Cell Therapy CDMO Business (2020-2025)
11.6.5 Pharmaron Recent Development
11.7 OBiO
11.7.1 OBiO Company Details
11.7.2 OBiO Business Overview
11.7.3 OBiO Cell Therapy CDMO Introduction
11.7.4 OBiO Revenue in Cell Therapy CDMO Business (2020-2025)
11.7.5 OBiO Recent Development
11.8 AGC Biologics
11.8.1 AGC Biologics Company Details
11.8.2 AGC Biologics Business Overview
11.8.3 AGC Biologics Cell Therapy CDMO Introduction
11.8.4 AGC Biologics Revenue in Cell Therapy CDMO Business (2020-2025)
11.8.5 AGC Biologics Recent Development
11.9 Cytiva
11.9.1 Cytiva Company Details
11.9.2 Cytiva Business Overview
11.9.3 Cytiva Cell Therapy CDMO Introduction
11.9.4 Cytiva Revenue in Cell Therapy CDMO Business (2020-2025)
11.9.5 Cytiva Recent Development
11.10 ThermoGenesis
11.10.1 ThermoGenesis Company Details
11.10.2 ThermoGenesis Business Overview
11.10.3 ThermoGenesis Cell Therapy CDMO Introduction
11.10.4 ThermoGenesis Revenue in Cell Therapy CDMO Business (2020-2025)
11.10.5 ThermoGenesis Recent Development
11.11 eXmoor Pharma
11.11.1 eXmoor Pharma Company Details
11.11.2 eXmoor Pharma Business Overview
11.11.3 eXmoor Pharma Cell Therapy CDMO Introduction
11.11.4 eXmoor Pharma Revenue in Cell Therapy CDMO Business (2020-2025)
11.11.5 eXmoor Pharma Recent Development
11.12 Advanced Therapies
11.12.1 Advanced Therapies Company Details
11.12.2 Advanced Therapies Business Overview
11.12.3 Advanced Therapies Cell Therapy CDMO Introduction
11.12.4 Advanced Therapies Revenue in Cell Therapy CDMO Business (2020-2025)
11.12.5 Advanced Therapies Recent Development
11.13 Catalent Biologics
11.13.1 Catalent Biologics Company Details
11.13.2 Catalent Biologics Business Overview
11.13.3 Catalent Biologics Cell Therapy CDMO Introduction
11.13.4 Catalent Biologics Revenue in Cell Therapy CDMO Business (2020-2025)
11.13.5 Catalent Biologics Recent Development
11.14 Patheon Pharma Services
11.14.1 Patheon Pharma Services Company Details
11.14.2 Patheon Pharma Services Business Overview
11.14.3 Patheon Pharma Services Cell Therapy CDMO Introduction
11.14.4 Patheon Pharma Services Revenue in Cell Therapy CDMO Business (2020-2025)
11.14.5 Patheon Pharma Services Recent Development
11.15 Sartorius
11.15.1 Sartorius Company Details
11.15.2 Sartorius Business Overview
11.15.3 Sartorius Cell Therapy CDMO Introduction
11.15.4 Sartorius Revenue in Cell Therapy CDMO Business (2020-2025)
11.15.5 Sartorius Recent Development
11.16 Genezen
11.16.1 Genezen Company Details
11.16.2 Genezen Business Overview
11.16.3 Genezen Cell Therapy CDMO Introduction
11.16.4 Genezen Revenue in Cell Therapy CDMO Business (2020-2025)
11.16.5 Genezen Recent Development
11.17 The Discovery Labs
11.17.1 The Discovery Labs Company Details
11.17.2 The Discovery Labs Business Overview
11.17.3 The Discovery Labs Cell Therapy CDMO Introduction
11.17.4 The Discovery Labs Revenue in Cell Therapy CDMO Business (2020-2025)
11.17.5 The Discovery Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Autologous Cell Therapy CDMO
 Table 3. Key Players of Allogeneic Cell Therapy CDMO
 Table 4. Key Players of Viral Vector and Gene Editing CDMO
 Table 5. Global Cell Therapy CDMO Market Size Growth Rate by Commercial Stage (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Key Players of Early-stage R&D CDMO
 Table 7. Key Players of Clinical Stage CDMO
 Table 8. Key Players of Commercial Production CDMO
 Table 9. Global Cell Therapy CDMO Market Size Growth Rate by Production Mode (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Key Players of Centralized Factory Model
 Table 11. Key Players of Distributed Regional Production Model
 Table 12. Global Cell Therapy CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 13. Global Cell Therapy CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 14. Global Cell Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 15. Global Cell Therapy CDMO Market Share by Region (2020-2025)
 Table 16. Global Cell Therapy CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 17. Global Cell Therapy CDMO Market Share by Region (2026-2031)
 Table 18. Cell Therapy CDMO Market Trends
 Table 19. Cell Therapy CDMO Market Drivers
 Table 20. Cell Therapy CDMO Market Challenges
 Table 21. Cell Therapy CDMO Market Restraints
 Table 22. Global Cell Therapy CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 23. Global Cell Therapy CDMO Market Share by Players (2020-2025)
 Table 24. Global Top Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2024)
 Table 25. Ranking of Global Top Cell Therapy CDMO Companies by Revenue (US$ Million) in 2024
 Table 26. Global 5 Largest Players Market Share by Cell Therapy CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 27. Global Key Players of Cell Therapy CDMO, Headquarters and Area Served
 Table 28. Global Key Players of Cell Therapy CDMO, Product and Application
 Table 29. Global Key Players of Cell Therapy CDMO, Date of Enter into This Industry
 Table 30. Mergers & Acquisitions, Expansion Plans
 Table 31. Global Cell Therapy CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 32. Global Cell Therapy CDMO Revenue Market Share by Type (2020-2025)
 Table 33. Global Cell Therapy CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 34. Global Cell Therapy CDMO Revenue Market Share by Type (2026-2031)
 Table 35. Global Cell Therapy CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 36. Global Cell Therapy CDMO Revenue Market Share by Application (2020-2025)
 Table 37. Global Cell Therapy CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 38. Global Cell Therapy CDMO Revenue Market Share by Application (2026-2031)
 Table 39. North America Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. North America Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 41. North America Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Europe Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Europe Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Europe Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Asia-Pacific Cell Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Asia-Pacific Cell Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 47. Asia-Pacific Cell Therapy CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 48. Latin America Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Latin America Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Latin America Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Middle East & Africa Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 52. Middle East & Africa Cell Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 53. Middle East & Africa Cell Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 54. Catalent Company Details
 Table 55. Catalent Business Overview
 Table 56. Catalent Cell Therapy CDMO Product
 Table 57. Catalent Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 58. Catalent Recent Development
 Table 59. Lonza Company Details
 Table 60. Lonza Business Overview
 Table 61. Lonza Cell Therapy CDMO Product
 Table 62. Lonza Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 63. Lonza Recent Development
 Table 64. Charles River Company Details
 Table 65. Charles River Business Overview
 Table 66. Charles River Cell Therapy CDMO Product
 Table 67. Charles River Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 68. Charles River Recent Development
 Table 69. FUJIFILM Diosynth Biotechnologies Company Details
 Table 70. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 71. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product
 Table 72. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 73. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 74. Exothera Company Details
 Table 75. Exothera Business Overview
 Table 76. Exothera Cell Therapy CDMO Product
 Table 77. Exothera Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 78. Exothera Recent Development
 Table 79. Pharmaron Company Details
 Table 80. Pharmaron Business Overview
 Table 81. Pharmaron Cell Therapy CDMO Product
 Table 82. Pharmaron Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 83. Pharmaron Recent Development
 Table 84. OBiO Company Details
 Table 85. OBiO Business Overview
 Table 86. OBiO Cell Therapy CDMO Product
 Table 87. OBiO Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 88. OBiO Recent Development
 Table 89. AGC Biologics Company Details
 Table 90. AGC Biologics Business Overview
 Table 91. AGC Biologics Cell Therapy CDMO Product
 Table 92. AGC Biologics Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 93. AGC Biologics Recent Development
 Table 94. Cytiva Company Details
 Table 95. Cytiva Business Overview
 Table 96. Cytiva Cell Therapy CDMO Product
 Table 97. Cytiva Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 98. Cytiva Recent Development
 Table 99. ThermoGenesis Company Details
 Table 100. ThermoGenesis Business Overview
 Table 101. ThermoGenesis Cell Therapy CDMO Product
 Table 102. ThermoGenesis Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 103. ThermoGenesis Recent Development
 Table 104. eXmoor Pharma Company Details
 Table 105. eXmoor Pharma Business Overview
 Table 106. eXmoor Pharma Cell Therapy CDMO Product
 Table 107. eXmoor Pharma Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 108. eXmoor Pharma Recent Development
 Table 109. Advanced Therapies Company Details
 Table 110. Advanced Therapies Business Overview
 Table 111. Advanced Therapies Cell Therapy CDMO Product
 Table 112. Advanced Therapies Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 113. Advanced Therapies Recent Development
 Table 114. Catalent Biologics Company Details
 Table 115. Catalent Biologics Business Overview
 Table 116. Catalent Biologics Cell Therapy CDMO Product
 Table 117. Catalent Biologics Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 118. Catalent Biologics Recent Development
 Table 119. Patheon Pharma Services Company Details
 Table 120. Patheon Pharma Services Business Overview
 Table 121. Patheon Pharma Services Cell Therapy CDMO Product
 Table 122. Patheon Pharma Services Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 123. Patheon Pharma Services Recent Development
 Table 124. Sartorius Company Details
 Table 125. Sartorius Business Overview
 Table 126. Sartorius Cell Therapy CDMO Product
 Table 127. Sartorius Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 128. Sartorius Recent Development
 Table 129. Genezen Company Details
 Table 130. Genezen Business Overview
 Table 131. Genezen Cell Therapy CDMO Product
 Table 132. Genezen Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 133. Genezen Recent Development
 Table 134. The Discovery Labs Company Details
 Table 135. The Discovery Labs Business Overview
 Table 136. The Discovery Labs Cell Therapy CDMO Product
 Table 137. The Discovery Labs Revenue in Cell Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 138. The Discovery Labs Recent Development
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. Authors List of This Report


List of Figures
 Figure 1. Cell Therapy CDMO Picture
 Figure 2. Global Cell Therapy CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Therapy CDMO Market Share by Type: 2024 VS 2031
 Figure 4. Autologous Cell Therapy CDMO Features
 Figure 5. Allogeneic Cell Therapy CDMO Features
 Figure 6. Viral Vector and Gene Editing CDMO Features
 Figure 7. Global Cell Therapy CDMO Market Size Comparison by Commercial Stage (2020-2031) & (US$ Million)
 Figure 8. Early-stage R&D CDMO Features
 Figure 9. Clinical Stage CDMO Features
 Figure 10. Commercial Production CDMO Features
 Figure 11. Global Cell Therapy CDMO Market Size Comparison by Production Mode (2020-2031) & (US$ Million)
 Figure 12. Centralized Factory Model Features
 Figure 13. Distributed Regional Production Model Features
 Figure 14. Global Cell Therapy CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 15. Global Cell Therapy CDMO Market Share by Application: 2024 VS 2031
 Figure 16. Commercial Case Studies
 Figure 17. Academic Research Case Studies
 Figure 18. Others Case Studies
 Figure 19. Cell Therapy CDMO Report Years Considered
 Figure 20. Global Cell Therapy CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Cell Therapy CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Cell Therapy CDMO Market Share by Region: 2024 VS 2031
 Figure 23. Global Cell Therapy CDMO Market Share by Players in 2024
 Figure 24. Global Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 25. The Top 10 and 5 Players Market Share by Cell Therapy CDMO Revenue in 2024
 Figure 26. North America Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 28. United States Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 32. Germany Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Ireland Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Cell Therapy CDMO Market Share by Region (2020-2031)
 Figure 40. China Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia & New Zealand Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 48. Mexico Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Cell Therapy CDMO Market Share by Country (2020-2031)
 Figure 52. Israel Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Cell Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Catalent Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 56. Lonza Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 57. Charles River Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 58. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 59. Exothera Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 60. Pharmaron Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 61. OBiO Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 62. AGC Biologics Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 63. Cytiva Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 64. ThermoGenesis Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 65. eXmoor Pharma Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 66. Advanced Therapies Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 67. Catalent Biologics Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 68. Patheon Pharma Services Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 69. Sartorius Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 70. Genezen Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 71. The Discovery Labs Revenue Growth Rate in Cell Therapy CDMO Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture